ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000254560.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.003719915	Sensitive
ENSG00000254560.1	ABT-263 (navitoclax)	Esophageal cancer	0.025045285	Sensitive